Ovarian cancer is one of the most lethal gynaecological malignancies worldwide. Despite
high success rates following first time treatment, this heterogenous disease is prone to …

Ovarian cancers are tumors that originate from the different cells of the ovary and account for
almost 4% of all the cancers in women globally. More than 30 types of tumors have been …

Currently available screening tests do not deliver the required sensitivity and specificity for
accurate diagnosis of ovarian or endometrial cancer. Infrared (IR) spectroscopy of blood …

Purpose: Intravenous delivery of oncolytic viruses often leads to tumor vascular shutdown,
resulting in decreased tumor perfusion and elevated tumor hypoxia. We hypothesized that …

Ovarian cancer (OC) is one of the commonest cancers of women in sub‐Saharan Africa
(SSA), although to date no data have been available on time trends in incidence to better …

Despite numerous advances in “omics” research, early detection of ovarian cancer still
remains a challenge. The aim of this study was to determine whether attenuated total …

Funding: Plaintiffs' attorneys in litigation against Johnson & Johnson (Ingham et al vs
Johnson & Johnson et al) paid for tissue analysis for talc and asbestos in patient tissues …

Introduction The mechanical interaction between cells and their microenvironment is
emerging as an important determinant of cancer progression and sensitivity to treatment …

Ovarian cancer accounts for 3% of all female cancers and has a high mortality rate among
gynecological malignancies. Early diagnosis carries a high survival rate of 93%. So, this …

Ovarian cancer is the deadliest gynecological cancer among women with an overall 5-year
survival rate below 50% due to its asymptomatic nature, diagnosis at advanced stages, and …